EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company,” a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced the launch of ...
Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses findings from the phase 3 Precision-T trial of Orca-T in acute leukemia and ...
Holdings announced the launch of its nationwide stem cell extraction, cryogenic storage and clinical delivery platform in ...
Leading regenerative medicine company, VetStem, Inc., has processed over 40,000 stem cell treatments for animals across the United States and Canada. Reaching 40,000 stem cell treatments is a ...
--License will enable expanded clinical operations for investigator-initiated trials and potential “right to try” uses of BRTX-100.— Licensure is an intensive and diligent process, and is required for ...
VetStem is a veterinarian-led Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, ...